You are here: Home » News-CM » Companies » Results
Business Standard

Astrazeneca Pharma India reports standalone net profit of Rs 29.09 crore in the December 2018 quarter

Capital Market 

Sales rise 67.41% to Rs 215.19 crore

Net profit of Astrazeneca Pharma India reported to Rs 29.09 crore in the quarter ended December 2018 as against net loss of Rs 10.35 crore during the previous quarter ended December 2017. Sales rose 67.41% to Rs 215.19 crore in the quarter ended December 2018 as against Rs 128.54 crore during the previous quarter ended December 2017. ParticularsQuarter EndedDec. 2018Dec. 2017% Var.Sales215.19128.54 67 OPM %18.99-8.43 -PBDT44.37-8.08 LP PBT40.59-11.81 LP NP29.09-10.35 LP

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, February 07 2019. 16:06 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU